FUNDAMENTAL  ||| S:0 E:12 ||| JJ
DIFFERENCES  ||| S:12 E:24 ||| NNP
BETWEEN  ||| S:24 E:32 ||| NNP
NATURAL  ||| S:32 E:40 ||| NNP
ANTIBODIES  ||| S:40 E:51 ||| NNP
AND  ||| S:51 E:55 ||| CC
POLYREACTIVE  ||| S:55 E:68 ||| NNP
IMMUNOGLOBULINS  ||| S:68 E:84 ||| NNP
A  ||| S:84 E:86 ||| DT
problem  ||| S:86 E:94 ||| NN
of  ||| S:94 E:97 ||| IN
similarity  ||| S:97 E:108 ||| NN
and  ||| S:108 E:112 ||| CC
differences  ||| S:112 E:124 ||| NNS
between  ||| S:124 E:132 ||| IN
so-called  ||| S:132 E:142 ||| JJ
polyreactive  ||| S:142 E:155 ||| JJ
immunoglobulins  ||| S:155 E:171 ||| NNS
( ||| S:171 E:172 ||| -LRB-
PRIGs ||| S:172 E:177 ||| NNP
)  ||| S:177 E:179 ||| -RRB-
and  ||| S:179 E:183 ||| CC
natural  ||| S:183 E:191 ||| JJ
antibodies  ||| S:191 E:202 ||| NNS
( ||| S:202 E:203 ||| -LRB-
NAbs ||| S:203 E:207 ||| NNP
) ||| S:207 E:208 ||| -RRB-
,  ||| S:208 E:210 ||| ,
capable  ||| S:210 E:218 ||| JJ
of  ||| S:218 E:221 ||| IN
cross-reacting  ||| S:221 E:236 ||| JJ
with  ||| S:236 E:241 ||| IN
some  ||| S:241 E:246 ||| DT
structurally  ||| S:246 E:259 ||| JJ
dissimilar  ||| S:259 E:270 ||| JJ
antigens ||| S:270 E:278 ||| NN
,  ||| S:278 E:280 ||| ,
has  ||| S:280 E:284 ||| VBZ
been  ||| S:284 E:289 ||| VBN
considered ||| S:289 E:299 ||| VBN
.  ||| S:299 E:301 ||| .
The  ||| S:301 E:305 ||| DT
analysis  ||| S:305 E:314 ||| NN
of  ||| S:314 E:317 ||| IN
mechanisms  ||| S:317 E:328 ||| NNS
of  ||| S:328 E:331 ||| IN
an  ||| S:331 E:334 ||| DT
unspecific  ||| S:334 E:345 ||| JJ
interaction  ||| S:345 E:357 ||| NN
between  ||| S:357 E:365 ||| IN
PRIGs  ||| S:365 E:371 ||| JJ
or  ||| S:371 E:374 ||| CC
NAbs  ||| S:374 E:379 ||| JJ
and  ||| S:379 E:383 ||| CC
antigens  ||| S:383 E:392 ||| JJ
evidences  ||| S:392 E:402 ||| NN
for  ||| S:402 E:406 ||| IN
the  ||| S:406 E:410 ||| DT
fact  ||| S:410 E:415 ||| NN
that  ||| S:415 E:420 ||| IN
essential  ||| S:420 E:430 ||| JJ
differences  ||| S:430 E:442 ||| NNS
exist  ||| S:442 E:448 ||| VBP
between  ||| S:448 E:456 ||| IN
these  ||| S:456 E:462 ||| DT
substances ||| S:462 E:472 ||| NNS
.  ||| S:472 E:474 ||| .
These  ||| S:474 E:480 ||| DT
differences  ||| S:480 E:492 ||| NNS
permit  ||| S:492 E:499 ||| VBP
classifying  ||| S:499 E:511 ||| VBG
the  ||| S:511 E:515 ||| DT
abovementioned  ||| S:515 E:530 ||| JJ
substances  ||| S:530 E:541 ||| NNS
as  ||| S:541 E:544 ||| IN
different  ||| S:544 E:554 ||| JJ
types  ||| S:554 E:560 ||| NNS
of  ||| S:560 E:563 ||| IN
immunoglobulin  ||| S:563 E:578 ||| JJ
molecules ||| S:578 E:587 ||| NNS
.  ||| S:587 E:589 ||| .
The  ||| S:589 E:593 ||| DT
major  ||| S:593 E:599 ||| JJ
difference  ||| S:599 E:610 ||| NN
between  ||| S:610 E:618 ||| IN
PRIGs  ||| S:618 E:624 ||| JJ
and  ||| S:624 E:628 ||| CC
NAbs  ||| S:628 E:633 ||| NNP
may  ||| S:633 E:637 ||| MD
include  ||| S:637 E:645 ||| VB
both  ||| S:645 E:650 ||| PDT
the  ||| S:650 E:654 ||| DT
mechanisms  ||| S:654 E:665 ||| NNS
of  ||| S:665 E:668 ||| IN
the  ||| S:668 E:672 ||| DT
above  ||| S:672 E:678 ||| RB
mentioned  ||| S:678 E:688 ||| VBN
immunoglobulin  ||| S:688 E:703 ||| JJ
molecules  ||| S:703 E:713 ||| NNS
binding  ||| S:713 E:721 ||| VBG
to  ||| S:721 E:724 ||| TO
antigens  ||| S:724 E:733 ||| VB
and  ||| S:733 E:737 ||| CC
their  ||| S:737 E:743 ||| PRP$
interaction  ||| S:743 E:755 ||| JJ
affinity ||| S:755 E:763 ||| NN
,  ||| S:763 E:765 ||| ,
as  ||| S:765 E:768 ||| RB
well  ||| S:768 E:773 ||| RB
as  ||| S:773 E:776 ||| IN
an  ||| S:776 E:779 ||| DT
absolutely  ||| S:779 E:790 ||| RB
different  ||| S:790 E:800 ||| JJ
influence  ||| S:800 E:810 ||| NN
of  ||| S:810 E:813 ||| IN
some  ||| S:813 E:818 ||| DT
low-molecular  ||| S:818 E:832 ||| JJ
substances  ||| S:832 E:843 ||| NNS
on  ||| S:843 E:846 ||| IN
the  ||| S:846 E:850 ||| DT
efficiency  ||| S:850 E:861 ||| NN
of  ||| S:861 E:864 ||| IN
the  ||| S:864 E:868 ||| DT
interaction  ||| S:868 E:880 ||| NN
with  ||| S:880 E:885 ||| IN
antigens ||| S:885 E:893 ||| NN
.  ||| S:893 E:895 ||| .
Relying  ||| S:895 E:903 ||| VBG
on  ||| S:903 E:906 ||| IN
the  ||| S:906 E:910 ||| DT
obtained  ||| S:910 E:919 ||| JJ
data  ||| S:919 E:924 ||| NNS
it  ||| S:924 E:927 ||| PRP
can  ||| S:927 E:931 ||| MD
be  ||| S:931 E:934 ||| VB
assumed  ||| S:934 E:942 ||| VBN
that ||| S:942 E:946 ||| IN
,  ||| S:946 E:948 ||| ,
since  ||| S:948 E:954 ||| IN
PRIGs  ||| S:954 E:960 ||| JJ
and  ||| S:960 E:964 ||| CC
NAbs  ||| S:964 E:969 ||| NNS
have  ||| S:969 E:974 ||| VBP
fundamental  ||| S:974 E:986 ||| JJ
differences ||| S:986 E:997 ||| NNS
,  ||| S:997 E:999 ||| ,
they  ||| S:999 E:1004 ||| PRP
may  ||| S:1004 E:1008 ||| MD
perform  ||| S:1008 E:1016 ||| VB
not  ||| S:1016 E:1020 ||| RB
only  ||| S:1020 E:1025 ||| RB
similar  ||| S:1025 E:1033 ||| JJ
but  ||| S:1033 E:1037 ||| CC
also  ||| S:1037 E:1042 ||| RB
different  ||| S:1042 E:1052 ||| JJ
functions  ||| S:1052 E:1062 ||| NNS
of  ||| S:1062 E:1065 ||| IN
the  ||| S:1065 E:1069 ||| DT
immune  ||| S:1069 E:1076 ||| JJ
system ||| S:1076 E:1082 ||| NN
.  ||| S:1082 E:1084 ||| .
